Accueil › Cancer du sein › Ohio › Cleveland
Essais cliniques pour Cancer du sein à Cleveland, OH
35 études pour Cancer du sein recherchent des participants dans et autour de Cleveland (dans un rayon d'environ 30 miles). Ouvrez une étude pour voir qui peut participer et comment contacter l'équipe.
Texte officiel de l'étude (anglais)
Vous recrutez pour une étude ? Mettez-la en avant en haut de cette page — $99 pour 30 jours →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Recrutement en coursPhase 1/2
- The Cleveland Clinic Taussig Cancer Center, Cleveland
A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Recrutement en coursPhase 2
- Cleveland Clinic - Oncology Department, Cleveland
Study of AVZO-021 in Patients With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- Avenzo Therapeutics Recruiting Site, Cleveland
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Recrutement en coursPhase 3
- Research Site, Cleveland
A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of BMS-986507 Combinations in Adult Participants With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- Cleveland Clinic, Cleveland
Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer
Recrutement en cours
- Cleveland Clinic, Cleveland
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Recrutement en coursPhase 3
- University Hospitals Cleveland Medical Center, Cleveland
- Fairview Hospital, Cleveland
- Cleveland Clinic - Hillcrest Hospital, Mayfield Heights · à 12 mi
A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations
Recrutement en coursPhase 1/2
- UH Cleveland Medical Center, Cleveland
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence
Recrutement en coursPhase 3
- MetroHealth, Cleveland
- Cleveland Clinic, Cleveland
Study to Investigate Efficacy of a Novel Probiotic on the Bacteriome and Mycobiome of Breast Cancer
Recrutement en cours
- Cleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center, Cleveland
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Recrutement en coursPhase 1
- University Hospital Cleveland Medical Center, Cleveland
- Cleveland Clinic, Cleveland
A Trial to Evaluate Ovarian Suppression Following Subcutaneous ZOLADEX 10.8 mg in Premenopausal Women With Early-stage and Advanced HR+ Breast Cancer
Recrutement en coursPhase 1
- Cleveland Clinic Foundation, Cleveland
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Recrutement en coursPhase 3
- Fairview Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
- Hillcrest Hospital, Mayfield Heights · à 12 mi
The Vanguard Study: Testing a New Way to Screen for Cancer
Recrutement en coursVolontaires sains bienvenus
- Louis Stokes Cleveland VA Medical Center, Cleveland
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
Recrutement en coursPhase 3
- Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
- South Pointe Hospital, Warrensville Heights · à 9 mi
- et 1 autres
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Recrutement en coursPhase 3
- Cleveland Clinic, Cleveland
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Recrutement en coursPhase 1
- Cleveland Clinic, Cleveland
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
Recrutement en coursPhase 1
- Cleveland Clinic Taussig Cancer Institute, Cleveland
Repeat Breast Conserving Surgery Followed by Daily Partial Breast Irradiation in Ipsilateral Breast
Recrutement en coursPhase 2
- University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center, Cleveland
- Cleveland Clinic Taussig Cancer Center, Case Comprehensive Cancer Center, Cleveland
Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
Recrutement en coursPhase 2
- Case Western Reserve University, Cleveland
TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients
Recrutement en cours
- Case Western Reserve University/University Hospitals Cleveland, Cleveland
Study of Ribociclib Administered Concurrently With Postoperative Radiation Therapy in Patients With High-Risk, HR+/HER2- Breast Cancer
Recrutement en coursPhase 1
- UHCMC Seidman Cancer Center, Cleveland
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1/2
- UH Cleveland Medical Center, Cleveland
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Recrutement en coursPhase 3
- University Hospitals Seidman Cancer Center, Cleveland
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
Recrutement en coursPhase 2
- Cleveland Clinic, Cleveland
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Recrutement en coursPhase 2
- Cleveland Clinic, Cleveland
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)
Recrutement en coursPhase 3
- Case Western Reserve University, Cleveland
- MetroHealth Medical Center, Cleveland
- Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
- et 3 autres
Evexomostat Plus PI3K or AKT Inhibitor and Fulvestrant in Patients With a PI3K Alteration and HR+/Her2- Breast Cancer
Recrutement en coursPhase 1/2
- Cleveland Clinic, Cleveland
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
Recrutement en coursÉtude observationnelle
- University Hospitals Seidman Cancer Center, Cleveland
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
Recrutement en coursÉtude observationnelle
- Cleveland Clinic Main Campus, Cleveland
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Recrutement en coursÉtude observationnelleVolontaires sains bienvenus
- Cleveland Clinic, Cleveland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Recrutement en coursÉtude observationnelle
- Massive Bio SYNERGY-AI site, Mayfield Heights · à 12 mi
The Cancer of the Pancreas Screening-5 CAPS5)Study
Recrutement en coursPhase 3
- Case Comprehensive Cancer Center, Case Western Medical Reserve, Cleveland
S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity
Recrutement en coursPhase 3
- Case Western Reserve University, Cleveland
- Cleveland Clinic Cancer Center/Fairview Hospital, Cleveland
- Cleveland Clinic Foundation, Cleveland
- et 3 autres
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Recrutement en coursPhase 1
- Exelixis Clinical Site #7, Cleveland
Essais pour Cancer du sein dans d'autres villes
- New York City, NY134 études
- Houston, TX126 études
- Boston, MA111 études
- Nashville, TN80 études
- Los Angeles, CA72 études
- Edison, NJ68 études
- St. Louis, MO64 études
- Durham, NC63 études
- Queens, NY63 études
- Chicago, IL58 études
- Philadelphia, PA56 études
- Dallas, TX55 études
Autres études à Cleveland
- Cancer du poumon non à petites cellules43 études
- Cancer (tous types)36 études
- Cancer de la prostate34 études
- Insuffisance cardiaque33 études
- Cancer métastatique30 études
- Cancer de l'ovaire30 études
- Cancer du poumon26 études
- Cancer colorectal24 études
- Maladie cardiovasculaire22 études
- Cancer de l'endomètre20 études
- Leucémie aiguë myéloïde20 études
- Maladie de Crohn19 études
Source : ClinicalTrials.gov, données récupérées le 5 oct. 2026. Chaque étude définit ses propres critères d'éligibilité ; l'équipe de l'étude décide qui peut y participer.